Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Steris Corp (STE)

Steris Corp (STE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Steris Corp 70 Sir John Rogerson`s Quay Dublin L2 D02 R296 IRL

www.steris.com Employees: 17,787 P: 353-1232-2000

Sector:

Medical

Description:

STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.

Key Statistics

Overview:

Market Capitalization, $K 25,618,330
Enterprise Value, $K 27,490,330
Shares Outstanding, K 98,147
Annual Sales, $ 5,460 M
Annual Net Income, $ 614,640 K
Last Quarter Sales, $ 1,460 M
Last Quarter Net Income, $ 191,900 K
EBIT, $ 1,021 M
EBITDA, $ 1,498 M
60-Month Beta 1.01
% of Insider Shareholders 1.07%
% of Institutional Shareholders 94.69%
Float, K 97,097
% Float 98.93%
Short Volume Ratio 0.72

Growth:

1-Year Return 21.09%
3-Year Return 37.15%
5-Year Return 41.38%
5-Year Revenue Growth 80.13%
5-Year Earnings Growth 63.48%
5-Year Dividend Growth 53.79%

Per-Share Information:

Most Recent Earnings 2.47 on 11/05/25
Next Earnings Date N/A
Earnings Per Share ttm 9.87
EPS Growth vs. Prev Qtr 5.56%
EPS Growth vs. Prev Year 15.42%
Annual Dividend & Yield 2.40 (0.92%)
Annual Dividend & Yield (Fwd) 2.52 (0.97%)
Most Recent Dividend 0.630 on 11/18/25
Next Ex-Dividends Date 11/18/25
Dividend Payable Date 12/18/25
Dividend Payout Ratio 23.62%
Most Recent Split 2-1 on 08/25/98

STE Ratios

Ratio
Price/Earnings ttm 26.28
Price/Earnings forward 25.37
Price/Earnings to Growth N/A
Return-on-Equity % 14.43%
Return-on-Assets % 9.52%
Profit Margin % 11.26%
Debt/Equity 0.27
Price/Sales 4.66
Price/Cash Flow 18.20
Price/Book 3.64
Book Value/Share 71.30
Interest Coverage 10.23

STE Dividends

Date Value
11/18/25 $0.6300
09/04/25 $0.6300
06/10/25 $0.5700
02/20/25 $0.5700
11/19/24 $0.5700
09/05/24 $0.5700
06/12/24 $0.5200
02/22/24 $0.5200
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar